Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (2070)	1/27/1998 1:19:00 PM
From: Dauntless	Read Replies (2) \| Respond to of 7041

Part of the problem is the EXPECTATION of information. IMHO, Zonagen's release of information is not unusual. Pharamceutical companies do not normally release extensive information from their clinical trials, FDA submissions and/or patent applications. I believe some people are demanding more detailed information to counter concerns brought up by Asensio or other shorts - all of which were deliberately misleading or false. Go check & see how much information has been released by Pfizer regarding Viagra - or any other comapnay at a similar stage. I hope that Zonagen continues to ignore all this crap & stays focused on the important stuff - namely, filing the NDA.